Out today in JAMA, in this Viewpoint available with free access, Jason H. Wasfy, M.D., James Januzzi Jr MD, and I pose the question:

Is Myocardial Infarction Overdiagnosed?

jamanetwork.com/journals/jama/…

Celebrating to our amazing Safia Chatur, MD for winning the ACC Young Investigator Award! Congratulations Safia, you’re such an inspiration to all of us 🥇Judy Hung mghecho Mass General Heart American College of Cardiology

EACVI survey on radiation exposure in interventional echocardiography revealing large variations and underuse of radioprotective measures across centers.

Large-scale studies, specific actions for implementing dedicated protective measures for interventional echocardiographer and…

2 yrs s/p ViV TAVR with 26 E Pro+ in a 25 CE with MI presentation- MG 9 in June 23, now 35. Huge sinuses, circular deployment.

Q: Are high-risk plaque features on coronary computed tomography angiography associated with vulnerable plaque on optical coherence tomography?

A: All 4 HRP features on CTA were associated with features of vulnerability on OCT.

Read more in #JACCIMG : bit.ly/3QqxQ1p

Take a look at our recently published manuscript describing PVE manifestations with multimodality imaging and pathology correlation
#Multimodality #ACCImaging #ACCFIT
#CVNuc ASNC Society

Our paper regarding early degeneration of Trifecta Valve that was commercialized as lower gradient/low PPM surgical valve. “Better” echo hemodynamics do not mean less future BVD Philippe Pibarot RTHahnMD Dr. Nicolas M Van Mieghem Cardiovascular Research Foundation William Suh, MD Thomas Pilgrim Tsuyoshi Kaneko Simon Dixon 🇳🇿

Deep Dive Slides #ACC2024 on SMART Trial. William Suh, MD Philippe Pibarot Amr Abbas thomas modine David J. Cohen, MD, MSc Mamas A. Mamas Dipti Itchhaporia, M.D., MACC , FAHA, FESC Athena Poppas, MD FACC NL valve w/ high gradient is NOT “dysfunction”-may be high EF! BEV EchoGradient > but CathGrad < SEV! MGrad and PPM not predictive!!

Special thanks to Ron Newman for recreating today’s eclipse in the cath lab for those of us stuck doing cases.

Congrats to the team! 🇮🇪☘️

A reminder of the limited generalizability of trials — classic trials of BB for MI were performed when other care was very different. Not clear that results of many classic old trials still hold today, with different other treatments and changing epidemiology of disease

#ACC24 REDUCE-AMI another blockbuster

Beta-blockers with NO reduction in myocardial infarction or death in pts with preserved EF post-MI

Massive finding likely with big implications for #Cardiology practice

Goodbye, old friend?? Beta-blocker therapy did not reduce death and MI in AMI with preserved LVEF at one year. nej.md/4akVhRx American College of Cardiology #ACC24

Congrats Safia Safia Chatur, MD and Muthu Muthu Vaduganathan! 🏆 It seems you were so casually preparing this between TEE cases last week 😂 Judy Hung mghecho

Anyone else already envisioning the MITHRAS-2 trial, where instead of closing the iatrogenic ASD following mitral TEER, its kept open with a V-wave device instead? Same goes for AF ablation… Very interesting results from RELIEVE-HF at #ACC24 American College of Cardiology

A patient with endocarditis and anterior mitral leaflet perforation, 3D TEE. Transillumination rendering is a great tool to highlight the orifice boundaries, as well as origin of the jet

Fascinating to see CT expanding into measuring ECV ('a CMR thing' and GLS ('an echo/CMR thing') now, in this case for risk prediction among patients undergoing TAVR.
jacc.org/doi/epdf/10.10…

Subaortic membrane

Echocardiographic estimation of pulmonary artery wedge pressure: invasive derivation, validation, and prognostic association beyond diastolic dysfunction grading

Read the full text in the last issue of #EHJCVI

European Society of Cardiology Journals EACVI President
#echofirst
academic.oup.com/ehjcimaging/ar…